Form 4: Hims & Hers CLO Sells Shares Under 10b5-1 Plan

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, sold 2,637 shares of Class A Common Stock for $58.79 per share pursuant to a pre-arranged trading plan.

Summary

• Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported a sale of Class A Common Stock.
• The transaction involved the disposition of 2,637 shares.
• The shares were sold at a price of $58.79 per share.
• The total value of the transaction was approximately $155,099.03.
• Following this transaction, Soleil Boughton beneficially owns 163,767 shares of Class A Common Stock.
• The sale was executed on September 29, 2025.
• This transaction was conducted pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan, which is generally considered a neutral event and does not indicate a change in company fundamentals or outlook.

Future Outlook

No forward-looking statements or guidance were provided in this Form 4 filing, which solely reports an insider transaction.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide information relevant to broader industry trends or competitor analysis.

Stakeholder Impact

• The sale by a Chief Legal Officer could be perceived by some shareholders as a minor reduction in insider ownership, though it was pre-scheduled under a 10b5-1 plan, mitigating negative interpretations.

Key Dates

Keywords

Hims & Hers Health, HIMS, Soleil Boughton, Insider Sale, Form 4, 10b5-1 Plan, Chief Legal Officer, Stock Transaction